Categories: News

Covetrus Announces First-Ever Chief Consumer Officer

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

New hire underscores commitment to enabling better healthcare outcomes via seamless digital and e-commerce experiences between veterinarians and their clients

PORTLAND, Maine–(BUSINESS WIRE)–$CVETCovetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of Deborah Sharkey as chief consumer officer (CCO). In this first-of-its-kind role for the company, Deborah will be responsible for developing innovative solutions that support and strengthen the relationship between veterinarian and pet owner.

“Like all modern consumers, pet owners desire convenience coupled with seamless delivery of products and services,” said Ben Wolin, Covetrus president and CEO. “With her dual background in e-commerce and consumer experience, Deborah will be instrumental in our mission to empower veterinarians to drive better health outcomes for animals, as well as helping extend veterinarians’ care beyond the walls of their practices.”

As CCO, Deborah Sharkey oversees marketing, product and strategy for the consumer group within Covetrus’ Global Technology Services which also encompasses the SmartPak brand.

“I am excited to join the largest global animal health company dedicated to veterinarians,” said Deborah Sharkey. “As an animal lover, my veterinarian is a family hero, and I am looking forward to applying my consumer expertise to this industry. With our technology, Covetrus is uniquely positioned to help veterinarians improve access to animal healthcare for pet owners and their beloved pets.”

Deborah brings extensive global e-commerce experience across both large tech company and startup environments, with a particular expertise in multi-customer marketplaces. Previously Deborah ran eBay’s Australia business and was its vice president of local marketplaces. She was also chief operating officer at DogVacay, which was acquired by Rover.com.

Covetrus will be participating in the 2021 Animal Health Innovation Europe forum taking place virtually on February 22 and 23. Deborah will be a panelist, along with other industry leaders addressing the timely topic of The Future of Pet Care Delivery in a Post Covid World. She will speak to Covetrus’ support of veterinary care today and into the future.

About Covetrus

Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. We are bringing together products, services, and technology into a single platform that connects our customers to the solutions and insights they need to work best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine with more than 5,500 employees serving over 100,000 customers around the globe. For more information about Covetrus visit https://covetrus.com/.

Contacts

Nicholas Jansen | Investor Relations

nicholas.jansen@covetrus.com | (207) 550-8106

Kiní Schoop | Public Relations

kini.schoop@covetrus.com | (207) 233-3539

Staff

Recent Posts

Sona Announces Successful Study Showing Absence of Endotoxins In Its Cancer Therapy Gold Nanorods Prior to First-in-human Clinical Trial

Halifax, Nova Scotia--(Newsfile Corp. - May 15, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB:…

1 hour ago

Mobile-health Network Solutions to Present at Sidoti Virtual Investor Conference, May 21-22, and Virtual Tech Conference, June 3-5

Singapore, Singapore--(Newsfile Corp. - May 15, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or…

2 hours ago

Vaso Corporation Announces Financial Results for First Quarter of 2025

PLAINVIEW, N.Y., May 15, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading…

2 hours ago

New Novartis data at ASCO and EHA showcase momentum of pioneering portfolio with promising pipeline

NATALEE subanalysis evaluates Kisqali in pre-menopausal early breast cancer patients, amid rising diagnosis rates in…

2 hours ago

PharmAla Biotech Launches Phenesafe AI Drug Discovery Platform for Novel Phenethylamines

TORONTO, May 15, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

2 hours ago

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

SAN DIEGO and LONDON and DUBLIN and SYDNEY, May 15, 2025 (GLOBE NEWSWIRE) -- Resmed…

2 hours ago